Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2011) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Natural Product Reports | journal | 3.285 Q1 | 211 | 82 | 218 | 15034 | 1973 | 209 | 9.13 | 183.34 |  |
| 2 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.326 Q1 | 99 | 24 | 80 | 3831 | 424 | 75 | 5.23 | 159.63 | |
| 3 | Critical Reviews in Toxicology | journal | 1.939 Q1 | 129 | 36 | 125 | 5090 | 716 | 116 | 5.88 | 141.39 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.973 Q2 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 | |
| 5 | Expert Opinion on Drug Delivery | journal | 1.689 Q1 | 133 | 111 | 295 | 11234 | 1677 | 290 | 5.70 | 101.21 | |
| 6 | Expert Opinion on Therapeutic Targets | journal | 1.575 Q1 | 106 | 112 | 352 | 10954 | 1340 | 348 | 4.13 | 97.80 | |
| 7 | Expert Opinion on Drug Discovery | journal | 0.621 Q2 | 84 | 92 | 288 | 8715 | 571 | 283 | 2.24 | 94.73 | |
| 8 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.018 Q1 | 100 | 120 | 369 | 11161 | 1500 | 365 | 3.53 | 93.01 | |
| 9 | Therapeutic Advances in Neurological Disorders | journal | 0.457 Q3 | 68 | 27 | 84 | 2375 | 149 | 76 | 1.98 | 87.96 | |
| 10 | Expert Opinion on Biological Therapy | journal | 1.312 Q1 | 102 | 141 | 459 | 11869 | 1848 | 452 | 4.34 | 84.18 | |
| 11 | Expert Opinion on Therapeutic Patents | journal | 1.129 Q1 | 88 | 112 | 329 | 9333 | 991 | 320 | 3.86 | 83.33 | |
| 12 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | |
| 13 | Trends in Pharmacological Sciences | journal | 5.422 Q1 | 244 | 90 | 249 | 6986 | 2845 | 232 | 11.29 | 77.62 | |
| 14 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | |
| 15 | Expert Review of Clinical Pharmacology | journal | 0.297 Q2 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
| 16 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | |
| 17 | Expert Review of Vaccines | journal | 1.405 Q1 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | |
| 18 | Neuropsychopharmacology | journal | 4.150 Q1 | 249 | 254 | 807 | 17601 | 6542 | 771 | 7.85 | 69.30 | |
| 19 | Cardiovascular Therapeutics | journal | 0.700 Q2 | 54 | 57 | 128 | 3887 | 288 | 115 | 2.19 | 68.19 | |
| 20 | Neuropharmacology | journal | 2.293 Q1 | 191 | 323 | 771 | 20594 | 3973 | 758 | 5.18 | 63.76 | |
| 21 | Molecular Diagnosis and Therapy | journal | 0.759 Q2 | 68 | 32 | 115 | 2040 | 280 | 108 | 1.96 | 63.75 | |
| 22 | Future Medicinal Chemistry | journal | 0.845 Q2 | 90 | 166 | 260 | 10362 | 506 | 196 | 1.95 | 62.42 | |
| 23 | Therapeutic Delivery | journal | 0.206 Q3 | 63 | 143 | 70 | 8885 | 53 | 69 | 0.76 | 62.13 | |
| 24 | Toxin Reviews | journal | 0.426 Q3 | 54 | 13 | 62 | 800 | 90 | 60 | 1.42 | 61.54 | |
| 25 | Journal of Psychopharmacology | journal | 1.194 Q1 | 135 | 166 | 501 | 10159 | 1617 | 451 | 3.18 | 61.20 | |
| 26 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 18 | 11 | 1092 | 22 | 11 | 2.00 | 60.67 | | |
| 27 | Biomarkers in Medicine | journal | 0.588 Q2 | 56 | 86 | 215 | 5033 | 442 | 176 | 2.32 | 58.52 | |
| 28 | Drug Discovery Today | journal | 1.928 Q1 | 215 | 139 | 444 | 8041 | 3049 | 410 | 6.59 | 57.85 | |
| 29 | International Journal of Neuropsychopharmacology | journal | 1.998 Q1 | 125 | 116 | 370 | 6709 | 1789 | 343 | 4.47 | 57.84 | |
| 30 | EPMA Journal | journal | 0.152 Q4 | 52 | 50 | 57 | 2820 | 48 | 52 | 0.84 | 56.40 | |
| 31 | Clinical Pharmacokinetics | journal | 1.861 Q1 | 184 | 61 | 180 | 3425 | 1157 | 165 | 5.84 | 56.15 | |
| 32 | Toxicological Sciences | journal | 1.890 Q1 | 207 | 292 | 853 | 16284 | 4345 | 800 | 4.89 | 55.77 | |
| 33 | Drug Discovery Today: Disease Mechanisms | journal | 0.504 Q2 | 28 | 15 | 78 | 807 | 107 | 70 | 1.15 | 53.80 | |
| 34 | BioDrugs | journal | 1.486 Q1 | 79 | 48 | 120 | 2573 | 568 | 114 | 4.12 | 53.60 | |
| 35 | Human Genomics | journal | 1.126 Q1 | 68 | 36 | 89 | 1912 | 262 | 75 | 3.08 | 53.11 | |
| 36 | Chinese Medicine | journal | 0.666 Q2 | 56 | 42 | 83 | 2193 | 215 | 75 | 2.48 | 52.21 | |
| 37 | Mutagenesis | journal | 1.092 Q1 | 102 | 102 | 201 | 5209 | 789 | 191 | 3.22 | 51.07 | |
| 38 | Pharmacogenomics | journal | 1.213 Q1 | 100 | 164 | 556 | 8344 | 2055 | 456 | 3.45 | 50.88 | |
| 39 | Toxicology Mechanisms and Methods | journal | 0.381 Q3 | 55 | 80 | 248 | 4028 | 298 | 242 | 1.23 | 50.35 | |
| 40 | Tetrahedron | journal | 1.473 Q1 | 236 | 1196 | 3799 | 59894 | 13155 | 3772 | 3.40 | 50.08 | |
| 41 | Journal of Applied Toxicology | journal | 0.820 Q2 | 103 | 91 | 302 | 4490 | 840 | 300 | 2.78 | 49.34 | |
| 42 | Fundamental and Clinical Pharmacology | journal | 0.663 Q2 | 85 | 83 | 252 | 4020 | 586 | 243 | 2.02 | 48.43 | |
| 43 | Environmental Pollution | journal | 2.041 Q1 | 301 | 486 | 1446 | 23044 | 6236 | 1425 | 4.17 | 47.42 | |
| 44 | Particle and Fibre Toxicology | journal | 2.760 Q1 | 119 | 34 | 94 | 1594 | 799 | 90 | 8.89 | 46.88 | |
| 45 | PharmacoEconomics | journal | 1.515 Q1 | 118 | 84 | 284 | 3908 | 926 | 227 | 2.76 | 46.52 | |
| 46 | Drug Discovery Today: Disease Models | journal | 0.364 Q3 | 33 | 24 | 79 | 1114 | 74 | 68 | 0.63 | 46.42 | |
| 47 | Toxicon | journal | 0.908 Q2 | 144 | 212 | 885 | 9582 | 2504 | 864 | 2.89 | 45.20 | |
| 48 | Pharmacogenomics Journal | journal | 1.494 Q1 | 95 | 49 | 144 | 2213 | 668 | 140 | 4.42 | 45.16 | |
| 49 | SAR and QSAR in Environmental Research | journal | 0.533 Q2 | 54 | 40 | 129 | 1795 | 269 | 128 | 2.04 | 44.88 | |
| 50 | Drug Safety | journal | 1.803 Q1 | 140 | 96 | 306 | 4277 | 1205 | 243 | 3.78 | 44.55 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data